טוען...
EGF Induced RET Inhibitor Resistance in CCDC6-RET Lung Cancer Cells
PURPOSE: Rearrangement of the proto-oncogene rearranged during transfection (RET) has been newly identified potential driver mutation in lung adenocarcinoma. Clinically available tyrosine kinase inhibitors (TKIs) target RET kinase activity, which suggests that patients with RET fusion genes may be t...
שמור ב:
| הוצא לאור ב: | Yonsei Med J |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Yonsei University College of Medicine
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5122657/ https://ncbi.nlm.nih.gov/pubmed/27873490 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2017.58.1.9 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|